Effectiveness of fluticasone furoate 110 μg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen

Current Medical Research and Opinion

Volumn 25, Issue 6, 2009, Pages 1393-1401

  Jacobs, Robert ^a   Martin, Bruce ^b   Hampel, Frank ^c   Toler, William ^d   Ellsworth, Anna ^d   Philpot, Edward ^d  

^a Biogenics Research Institute   (United States)

^b Southwest Allergy and Asthma Research   (United States)

^c Central Texas Health Research   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Fluticasone furoate; Intranasal corticosteroids; Juniperus ashei; Mountain cedar; Nasal spray; Nasal symptoms; Ocular symptoms; Seasonal allergic rhinitis

Indexed keywords

FLUTICASONE FUROATE;

ADOLESCENT; ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; EPIPHORA; EPISTAXIS; EYE BURNING; FEMALE; HAY FEVER; HEADACHE; HUMAN; JUNIPERUS; JUNIPERUS ASHEI; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; NASAL PRURITUS; NAUSEA; NOSE CONGESTION; OCULAR PRURITUS; PHASE 3 CLINICAL TRIAL; POLLEN ALLERGY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; RHINORRHEA; SCHOOL CHILD; SCORING SYSTEM; SINUS HEADACHE; SNEEZING; SORE THROAT; TREATMENT RESPONSE;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AGED; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; CEDRUS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EYE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NOSE DISEASES; PLACEBOS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649429419     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990902890512     Document Type: Article

References (21)

1. Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998;81:478-518 (Pubitemid 28553778)
2. Canonica GW, Bousquet J, Mullol J, et al. A survey of the burden of allergic rhinitis in Europe. Allergy 2007;62(Suppl 85):17-25 (Pubitemid 47561569)
3. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy 2007;62(Suppl 85):9-16 (Pubitemid 47561568)
4. Blanc PD, Trupin L, Eisner M, et al. The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol 2001;54:610-618 (Pubitemid 32453355)
5. Walker S, Khan-Wasti S, Fletcher M, et al. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol 2007;120:381-387
6. Task Force on Allergic Disorders. The Allergy Report. (Available at http://www.theallergyreport.com) Volume 1. 2000. Milwaukee, WI, American Academy of Allergy, Asthma and Immunology. Accessed 21 June 2007
7. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63:8-160
8. Price D, Bond C, Bouchard J, et al. International Primary Care Respiratory Group (IPCRG) Guidelines: Management of allergic rhinitis. Prim Care Respir J 2006;15:58-70 (Pubitemid 43155767)
9. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998;317:1624-1629 (Pubitemid 28554544)
10. Bernstein DI, Levy AL, Hampel FC, et al. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy 2004;34:952-957 (Pubitemid 38824075)
11. DeWester J, Philpot EE, Westlund RE, et al. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc 2003;24:331-337 (Pubitemid 37414434)
12. Bielory L, Katelaris CH, Lightman S, et al. Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders. MedGenMed 2007;9:35 (Pubitemid 47263998)
13. Berger WE, Godfrey JW, Slater AL. Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance. Expert Opin Drug Deliv 2007;4:689-701 (Pubitemid 350193403)
14. Allen A, Down G, Newland A, et al. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects. Clin Ther 2007;29:1415-1420 (Pubitemid 47354209)
15. Salter M, Biggadike K, Matthews JL, et al. Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. Am J Physiol Lung Cell Mol Physiol 2007;293:660-667 (Pubitemid 47358828)
16. Fokkens WJ, Jogi R, Reinartz S, et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 2007;62:1078-1084 (Pubitemid 47220983)
17. Kaiser HB, Naclerio RM, Given J, et al. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 2007;119:1430-1437 (Pubitemid 46855849)
18. Martin BG, Ratner PH, Hampel FC, et al. Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents. Allergy Asthma Proc 2007;28:216-225
19. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994;93:413-423 (Pubitemid 24081781)
20. Naclerio RM, Pinto J, deTineo M, et al. Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc 2008;29:24-28
21. Rosenblut A, Bardin PG, Muller B, et al. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. Allergy 2007;62:1071-1077 (Pubitemid 47220982)